Colgate-Palmolive consensus shapes the outlook, shares tracked against consumer staples peers

Analysts maintain a steady view on Colgate-Palmolive, with the S&P 500 consumer staples member compared closely to rivals like Procter & Gamble and Unilever in valuation and growth expectations.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-28, 11:46.

Colgate-Palmolive (US1941621039) sits firmly in the S&P 500 consumer staples cohort, with its shares listed on the NYSE under the ticker CL. The current analyst consensus around the stock provides a structured view of expected earnings and valuation multiples across the next 12 to 24 months, with key houses continuing to publish updated models.

What current analyst data shows

Consensus data compiled by MarketBeat indicates that Colgate-Palmolive is followed by a broad group of Wall Street firms, with ratings spanning Buy, Hold and occasional Sell recommendations, and an aggregated consensus price target that frames expectations for the NYSE-listed shares. The data set includes inputs from houses such as Morgan Stanley, Citi and JPMorgan, which periodically refresh their earnings per share and revenue estimates for the consumer products group, anchoring valuation discussions around forward multiples and dividend stability.

Analyst commentary typically benchmarks Colgate-Palmolive against peers like Procter & Gamble and Unilever, noting that the company’s margin profile and organic sales growth sit within a relatively tight band compared with sector averages. Research notes highlight the defensive characteristics of the business, with recurring demand for oral care, home care and personal care products supporting earnings visibility in both developed and emerging markets.

Valuation and sector comparison today

At the last available close, Colgate-Palmolive shares traded at around 92 dollars on the NYSE, reflecting a valuation that analysts often compare with the broader consumer staples sector and the S&P 500 index. MarketBeat data points to a price-to-earnings ratio that is typically above the S&P 500 average but broadly in line with other large-cap household and personal care names, driven by perceived brand strength and cash generation.

Sector-focused reports note that Colgate-Palmolive’s dividend yield contributes meaningfully to total shareholder return, complementing modest volume growth and pricing initiatives in categories such as toothpaste and dishwashing detergents. In this context, the shares are frequently described as a core defensive holding within consumer staples portfolios, with analysts monitoring input cost trends and currency movements as key factors for future margin development.

How Colgate-Palmolive makes its money

Colgate-Palmolive generates most of its revenue from branded consumer products, with global oral care lines such as Colgate toothpaste and toothbrushes at the core of its portfolio. The group also sells home care items, including dishwashing liquids, surface cleaners and fabric conditioners, alongside personal care products under the Palmolive brand and pet nutrition through Hill’s, providing a diversified stream of cash flows across regions and categories.

Where the stock trades today

The Colgate-Palmolive shares (US1941621039) last closed on the NYSE at 92.06 dollars on 2026-06-26, 15:59 Eastern, according to MarketBeat data.

Key data on the Colgate-Palmolive shares

• Company: Colgate-Palmolive Company
• ISIN: US1941621039
• WKN: 850667
• Ticker: CL
• Trading venue: NYSE
• Price (as of 2026-06-26, 15:59): 92.06 USD
• Market cap: approximately 76 billion USD (as of 2026-06-26, based on the latest reported figure and share price).
• Sector / industry: Consumer staples / household & personal care products
• Index membership: S&P 500
• Next earnings date: not officially scheduled

This text is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities.